Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase EARLY_PHASE1 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Cardiovascular Diseases 1

Interventions

pembrolizumab 223 Carboplatin 218 Cisplatin 205 Paclitaxel 182 Gemcitabine 149 Docetaxel 127 Capecitabine 114 Dexamethasone 102 Pemetrexed 101 Cyclophosphamide 101 Specimen Handling 99 Magnetic Resonance Spectroscopy 97 Oxaliplatin 96 Radiotherapy 95 Doxorubicin 91 Fluorouracil 87 Bevacizumab 83 Nivolumab 74 Leucovorin 72 Rituximab 70 Vincristine 67 durvalumab 66 Lenalidomide 63 Etoposide 62 atezolizumab 61 Radiation 61 Irinotecan 60 130-nm albumin-bound paclitaxel 57 Prednisone 56 Letrozole 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Fatty Acids, Omega-3 × 1 year × Clear all

NCT01169259 2025-11-06

VITAL

Brigham and Women's Hospital

Phase 3 Active not recruiting

25,871 enrolled 38 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡